Skip to content
Capital Markets & Securities

Non-GAAP Financial Measures Disclosure Under NI 52-112

NI 52-112 requires Canadian issuers to label, reconcile and explain non GAAP financial measures and never present them more prominently than IFRS figures. With IFRS 18 effective from 2027, the CSA adopted amendments on 15 October 2026, due in force on 29 December 2026, to keep management-defined performance measures within the rules.

Reconciliation table for non GAAP financial measures in a Canadian issuer's MD&A

Key takeaways

  • Non GAAP financial measures need a clear label, a reconciliation and an explanation of usefulness.
  • They may not be more prominent than the most directly comparable IFRS measure.
  • IFRS 18 applies to annual periods beginning on or after 1 January 2027.
  • CSA amendments published 15 October 2026 keep management-defined performance measures within NI 52-112.
  • A new prominence rule applies to additional subtotals disclosed outside the financial statements.

What NI 52-112 requires for non GAAP financial measures

National Instrument 52-112 Non-GAAP and Other Financial Measures Disclosure governs how Canadian reporting issuers disclose non GAAP financial measures, such as adjusted EBITDA, adjusted net income, free cash flow and organic growth, and related ratios and supplementary measures. In short, the instrument requires that each measure be clearly labelled, presented with no more prominence than the most directly comparable measure in the primary financial statements, reconciled to that measure, explained, and given comparative figures. The rules apply to disclosure in documents filed with regulators and, with some adjustments, to news releases, presentations and other public statements.

Reconciliation table for non GAAP financial measures in a Canadian issuer's MD&A
Non GAAP financial measures must be labelled, reconciled and presented with no more prominence than IFRS figures.

The rules are changing again. IFRS 18 Presentation and Disclosure in Financial Statements takes effect for annual reporting periods beginning on or after 1 January 2027 and requires disclosure of management-defined performance measures in a note to the financial statements. On 15 October 2026, the Canadian Securities Administrators (CSA) published final amendments to NI 52-112 to keep those measures within the instrument when they appear outside the financial statements; subject to approvals, the amendments come into force on 29 December 2026. This note explains the current rules, the IFRS 18 amendments and the issues regulators most often raise.

The categories of measures

CategoryWhat it isMain requirements
Non-GAAP financial measureA measure of historical or expected financial performance, position or cash flow, not disclosed in the financial statements, that excludes or includes amounts not in the most directly comparable financial statement measure (e.g., adjusted EBITDA)Label; prominence; reconciliation; explanation of composition and usefulness; comparatives
Non-GAAP ratioA ratio, fraction or percentage with a non-GAAP financial measure as a component (e.g., adjusted EBITDA margin)Identify the non-GAAP component and comply for it; explain the ratio
Total of segments measures, capital management measuresMeasures disclosed in the notes to the financial statements but presented outside themSpecified explanations or reconciliations
Supplementary financial measuresMeasures disclosed periodically that are not in the financial statements and are not non-GAAP measures (e.g., same-store sales)Explanation of composition
Management-defined performance measures (from IFRS 18)Subtotals of income and expenses used in public communications and disclosed in a note under IFRS 18Amendments keep NI 52-112 requirements applying when disclosed outside the financial statements

Forward-looking non-GAAP financial measures, such as guidance for adjusted EBITDA, are covered too, with requirements to describe significant differences from the equivalent historical measure and to provide a reconciliation or explanation where possible.

Labels, prominence and reconciliation

The core obligations for non GAAP financial measures are straightforward to state and easy to get wrong in practice:

  • Label. The measure must be labelled in a way that describes its composition, and must not use a label that is the same as or confusingly similar to an IFRS measure.
  • Prominence. The measure may not be presented with more prominence than the most directly comparable measure in the primary financial statements. In practice, that means the IFRS figure appears first, or at least as prominently, in headings, tables and charts.
  • Reconciliation. A quantitative reconciliation to the most directly comparable financial statement measure, with each reconciling item explained, must be provided, or incorporated by reference from the MD&A where the instrument permits.
  • Explanation. The issuer must explain the composition of the measure and how it provides useful information to investors, and the additional purposes, if any, for which management uses it.
  • Comparatives and changes. Comparative period figures must be presented, and changes in composition must be explained.
Practical point

Build the reconciliation tables first and draft the news release around them. If a measure cannot be reconciled cleanly to an IFRS line item, that is a sign it may be misleading or poorly defined, and it is better to fix the definition before regulators ask.

The IFRS 18 amendments to NI 52-112

IFRS 18 introduces defined subtotals in the statement of profit or loss, such as operating profit, and requires companies to disclose management-defined performance measures (MPMs), meaning subtotals of income and expenses used in public communications outside the financial statements to communicate management's view of performance, in a single note to the financial statements, with a reconciliation. Without amendment, measures such as adjusted operating profit, which have historically been non GAAP financial measures, might have fallen outside NI 52-112 once disclosed in the notes.

According to the CSA's 15 October 2026 release, the final amendments:

  • ensure that measures historically subject to NI 52-112 remain subject to it after IFRS 18 is adopted, so MPMs disclosed outside the financial statements remain subject to the instrument's disclosure requirements;
  • introduce a prominence requirement for an additional subtotal disclosed outside the financial statements, consistent with IFRS 18's rule that an additional subtotal on the face of a primary statement be displayed no more prominently than the totals and subtotals IFRS requires; and
  • come into force on 29 December 2026, subject to all necessary approvals.

The amendments followed a consultation launched in November 2025. Issuers adopting IFRS 18 for 2027 year-ends, and particularly those planning early adoption, should map each existing non GAAP measure to its post-IFRS 18 category now.

Which documents are covered

NI 52-112 applies to disclosure in documents filed with or delivered to regulators, such as MD&A, annual information forms, prospectuses, circulars and news releases filed on SEDAR+. It also applies to other documents and oral statements, such as investor presentations, websites and earnings calls, to the extent the instrument and related guidance provide. Many issuers apply the same discipline to all public communications to avoid inconsistency, and route investor materials through the same disclosure committee review as filed documents. Measures that appear in an earnings call script, a slide deck or a social media post should match the defined, reconciled measures in the MD&A.

Typical regulatory comments

CSA staff reviews of continuous disclosure regularly identify the same presentation deficiencies:

  1. headlines or bullet points that present an adjusted figure before, or without, the IFRS figure;
  2. labels such as "adjusted net income" without a clear description of adjustments;
  3. recurring cash operating expenses removed as "non-recurring" or "one-time";
  4. reconciliations that start from a figure other than the most directly comparable financial statement measure;
  5. missing explanations of why the measure is useful;
  6. changes in definition from period to period without explanation; and
  7. forward-looking non-GAAP targets with no reconciliation or explanation.

Regulators can require restatement or refiling of deficient documents and may add the issuer to a public list of defaulting issuers in serious cases, and serious cases can lead to enforcement. Misleading non-GAAP presentation can also support misrepresentation claims in secondary market litigation. Our note on timely disclosure explains how disclosure documents feed into liability.

Governance of non GAAP financial measures

Audit committees should oversee the use of adjusted and other non-IFRS measures as part of their review of financial disclosure. Good practice includes a written policy defining each measure the issuer uses, approval of new measures and changes by the audit committee, consistency across MD&A, news releases and presentations, and review by the external auditor where appropriate (auditors do not audit non GAAP measures but often read them for consistency). Measures used in executive compensation plans should be defined consistently with public disclosure, or the differences explained in the compensation discussion and analysis; see our note on executive compensation disclosure.

Preparing for IFRS 18 and the amendments

Issuers should not wait for their first IFRS 18 financial statements to think about these measures and how they will be presented alongside the new subtotals. A practical preparation plan includes:

  1. listing every measure currently used in MD&A, news releases, presentations, compensation plans and lender reporting;
  2. classifying each one under the post-IFRS 18 framework: an IFRS-defined subtotal, an MPM disclosed in the notes, a non-GAAP financial measure, a ratio or a supplementary measure;
  3. deciding which measures to keep, retire or redefine, recognizing that MPMs will be audited as part of the financial statements;
  4. updating labels and reconciliation templates for the new subtotals such as operating profit; and
  5. briefing the audit committee and investor relations team on the changes, so that messaging to analysts is consistent.

The text of NI 52-112 and related CSA materials are available from each regulator, for example on the Alberta Securities Commission's instrument page. Issuers with fiscal years that do not match the calendar year should check carefully when IFRS 18 first applies to them.

Non GAAP financial measures in offerings and transactions

Prospectuses, offering memoranda, take-over bid circulars and information circulars for business combinations frequently include non GAAP financial measures, especially for targets in acquisitions. Those documents carry statutory liability, and regulators review them closely before issuing receipts. Pro forma adjusted figures, run-rate synergies and "adjusted" figures for acquired businesses need especially careful presentation and reconciliation. Underwriters' due diligence typically includes a review of the definitions and calculations, and comfort letters may cover the underlying financial data. Using the same definitions as in continuous disclosure documents avoids difficult questions about why a measure changed for marketing purposes.

Common adjustments and where they go wrong

Adjustments for share-based compensation, acquisition costs, restructuring charges, impairments, foreign exchange and fair value changes are common and usually acceptable if explained. Problems arise when an issuer labels a recurring cost as "non-recurring", excludes normal cash operating expenses to inflate a performance measure, or adjusts for items selectively, removing losses but not gains. Regulators look at the pattern over time: a restructuring charge that appears every year is hard to describe as unusual. The explanation of usefulness should reflect how management actually uses the measure, not a generic statement. Tax effects and non-controlling interests should be shown consistently in reconciliations, and per-share figures based on adjusted earnings deserve particular care because they are easily mistaken for IFRS earnings per share.

Cross-border issuers and US rules

Canadian issuers registered with the SEC must also comply with US rules on non-GAAP measures, including Regulation G and, for filed documents, the requirements of Item 10(e) of Regulation S-K as they apply to foreign private issuers, together with SEC staff guidance. The Canadian and US regimes are similar in principle, with both emphasizing equal or greater prominence of the GAAP measure and reconciliation, but their details differ, and SEC staff comments can be more prescriptive about specific adjustments. Issuers should design a single set of measures that satisfies both regimes. See our note on Canadian foreign private issuers.

How TRW & Co helps

We review non GAAP financial measures in MD&A, news releases and investor materials, design compliant reconciliation tables and definitions, prepare issuers for IFRS 18 and the 2026 amendments to NI 52-112, respond to CSA staff comment letters and coordinate with US requirements for cross-listed issuers. See our continuous disclosure compliance page. This note is general information, not legal advice. To discuss your disclosure, contact us.

Frequently asked questions

What is a non-GAAP financial measure under NI 52-112?

Broadly, a measure of historical or expected financial performance, position or cash flow that is not disclosed in the financial statements and that excludes or includes amounts not in the most directly comparable financial statement measure. Adjusted EBITDA and free cash flow are common examples.

What must accompany a non-GAAP measure?

A label describing its composition, presentation with no more prominence than the most directly comparable financial statement measure, a quantitative reconciliation to that measure, an explanation of its composition and usefulness, and comparative period figures, with changes in definition explained.

How does IFRS 18 affect NI 52-112?

IFRS 18, effective for annual periods beginning on or after 1 January 2027, requires management-defined performance measures to be disclosed in a note. The CSA's final amendments, published on 15 October 2026, keep these measures subject to NI 52-112 when disclosed outside the financial statements and add a prominence rule for additional subtotals.

When do the NI 52-112 amendments take effect?

Subject to all necessary approvals, on 29 December 2026, according to the CSA's 15 October 2026 release. Issuers should map their existing measures to the new framework ahead of their first IFRS 18 reporting periods.

Do the rules apply to investor presentations and earnings calls?

NI 52-112 focuses on documents filed or delivered and also reaches other public statements as the instrument and guidance provide. Most issuers apply the same definitions and reconciliations across all communications, because inconsistent measures attract regulatory comment and litigation risk.

Sources

  1. CSA: CSA updates non-GAAP and other financial measures disclosure rules ahead of IFRS 18 (15 October 2026)
  2. ASC: National Instrument 52-112
  3. CSA Notice and Request for Comment on proposed NI 52-112 amendments (13 November 2025, BCSC)

General information only, not legal advice. References to statutes, courts and authorities describe published law and practice at the date shown.